Mevion Medical Systems

Executive Summary

Mevion Medical Systems is a UK-based private company specializing in proton therapy systems for cancer treatment. Founded in 2004, Mevion has achieved significant regulatory milestones, including CE marking and FDA clearance for its MEVION S250-FIT system. The company is expanding its footprint through partnerships with leading healthcare providers such as UNC Health and Carilion Clinic, with plans to bring advanced proton therapy to Central Massachusetts and Southwest Virginia. These developments position Mevion as a key player in the radiopharmaceuticals sector, addressing the growing demand for precise, less invasive cancer treatments. With a focus on innovation and market expansion, Mevion continues to validate its technology and commercial viability.

Upcoming Catalysts (preview)

• Q3 2026Commercial launch of MEVION S250-FIT in Europe80% success
• Q4 2026Expansion of US proton therapy centers via new hospital partnerships70% success
• H1 2027Announcement of next-generation proton therapy system50% success